
The Rising Star of GeneDx in the Race for Multibagger Supremacy by 2025
GeneDx Holdings Corp. (NASDAQ:WGS) is a dynamic player in the genomics field, gaining attention for its potential as a multibagger by 2025. The company excels in genetic testing for rare diseases, contributing to personalized medicine through comprehensive genome sequencing and specialized gene